The Kavanaugh Hearings; Drug Exchanges

Oct 1, 2018

Like many Americans, our newsroom was glued to the eight or so hours of testimony by Dr. Christine Blasey-Ford and Judge Brett Kavanaugh during last week's Senate Judiciary Hearings, including the dramatic committee vote on Friday that led to a limited FBI investigation. 

Emotions were raw. Pain, anger, grievance and frustration were experienced in the Senate chamber and in workplaces and homes across the country. By Saturday, the country was exhausted. 

Unfortunately, there will be no time this week to contemplate what we each experienced. Reports of limits to the FBI investigation and interference by the White House has led to a new round of questions about democratic norms and civility in the partisan war for the Supreme Court.

We decided to give you a break from the hearings in our final segment. 

Also this hour: More than 100 people overdosed in New Haven in August after ingesting synthetic marijuana laced with Fubinaca, a synthetic drug that mimics the effects of marijuana but is more potent.

Synthetic drugs are flooding the market because they're easy, quick, and lucrative to the amateur chemists who make them. But they're involved in almost triple the number of deaths annually as guns.

Is it time to consider drug exchanges?


  • Margaret Carlson - Columnist at The Daily Beast (@carlsonmargaret)
  • Ian Ayres - William K. Townsend professor at Yale Law School and professor at Yale’s School of Management. His latest book is Carrots and Sticks: Unlock the Power of Incentives to Get Things Done. (@iayres)

Join the conversation on Facebook and Twitter

Colin McEnroe and Chion Wolf contributed to this show.